FMC stock gets a lower Goldman Sachs price target

Published on 10/03/2026 at 22:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

FMC stock was last at EUR 39.55 on Xetra on October 2, 2026, while Goldman Sachs kept its Neutral rating. Q2 operating income growth reached 23 percent.

Moderner Dialyseraum mit Hämodialysegeräten und Patientenliegen bei Tageslicht — Ein fotorealistisches Bild eines modernen Dialyseraums mit mehreren Hämodialysegeräten und Patientenliegen in Reihe, ruhigem Tageslicht durch große Fenster – typisch für die Behandlungszentren von Fresenius Medical Care AG (ISIN DE0005785802), Illustration mit AI erstellt.

FMC stock (ISIN DE0005785802) was last at EUR 39.55 on Xetra on October 2, 2026, with a market capitalization of EUR 10.5 billion. The immediate catalyst is a lower Goldman Sachs valuation, while the company continues to report higher operating profitability.

Goldman Sachs lowers target

According to FinanzNachrichten on September 30, 2026, Goldman Sachs cut its FMC price target from EUR 39 to EUR 38 and kept its Neutral rating. The analyst forecast adjusted operating income of EUR 524 million, which was above consensus, but treatment-volume growth was expected to remain limited.

The target change gives FMC stock a concrete valuation checkpoint. The EUR 38 target is EUR 1.55 below the October 2 Xetra price, so the new estimate sits below the latest reference price rather than implying an upside case.

Operating profit rises 23 percent

In its August 3, 2026 second-quarter release, Fresenius Medical Care reported 23 percent growth in adjusted operating income. The company also said its 5008X CAREsystem was available in 227 US clinics and had been used in more than 600,000 treatments.

That combination creates a clear split in the current picture: Goldman Sachs is cautious on treatment growth, while FMC highlights technology rollout and profitability. The operating-income figure is therefore the key counterweight to the lower target.

Stock remains below yearly high

FMC stock was last at EUR 39.55 on October 2, 2026, after opening at EUR 39.57 and trading between EUR 39.28 and EUR 39.75. The daily change was minus 0.33 percent, and the last price stood below the 52-week high of EUR 47.86 while remaining above the 52-week low of EUR 34.57.

The Xetra snapshot also showed 504,415 shares traded. Fresenius Medical Care's investor calendar lists November 3, 2026, for the publication of third-quarter results and the conference call, giving the next major operating checkpoint a fixed date.